Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Saitama
Clinical trial register · Japan

Clinical Trials in Saitama, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Aichi 10 Fukuoka 9 Kanagawa 9 Tokyo 8 Chiba 7
Narrow the registerReset
Recruitment status
Phase
Site location
Aichi10 Fukuoka9 Kanagawa9 Tokyo8 Chiba7
All 95 locations
Target enrolment
to

Trials with a site in Saitama

6 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Novo Nordisk A/S
Phase 2
465
Koriyama-shi, Fukushima, Aichi, Ibaraki, Kanagawa, Kita-ku, Tokyo, Saitama, Sendai-shi, Miyagi, Siga
2024-12-02
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Aichi, Gunma, Nara, Saitama, Tochigi, Tokyo
2023-02-13
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Sapporo, Suita-shi, Aichi, Chiba-shi, Chiba, Gunma, Kanagawa, Osaka, Saitama
2022-11-01
Active, closed
Novo Nordisk A/S
Phase 3
153
Kanagawa, Saitama
2022-03-24
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
Novo Nordisk A/S
Phase 3
156
Aichi, Hiroshima, Hyōgo, Niigata, Osaka, Saitama, Shizuoka, Tokyo
2019-11-13
Active, closed
Novo Nordisk A/S
Phase 3
134
Aichi, Kagoshima, Kanagawa, Mie, Nara, Saitama, Tokyo
2019-10-21
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/saitama

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies with a site in Saitama that also match the filters currently applied.

How many clinical trials are recruiting in Saitama?

1 of the 6 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Saitama), 6 studies
PhaseStudiesRecruitingShare
Phase 35083.3%
Phase 21116.7%

Most active sponsors

Lead sponsors with the most studies (Saitama)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S61
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.